(Q34751517)

4 August 2017

Hyperforin as a possible antidepressant component of hypericum extracts (English)

1 reference

4 August 2017

S S Chatterjee

1

1 reference

4 August 2017

S K Bhattacharya

2

1 reference

4 August 2017

M Wonnemann

3

1 reference

4 August 2017

A Singer

4

1 reference

4 August 2017

W E Müller

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

4 August 2017

1 reference

4 August 2017

63

1 reference

4 August 2017

499-510

1 reference

4 August 2017

6

1 reference

Controlled clinical trials of hypericum extracts in depressed patients--an overview

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

St John's wort as an antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Failure to escape traumatic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Human monoamine oxidase. Lack of brain and platelet correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

On closed testing procedures with special reference to ordered analysis of variance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

The validity of animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Treating depression and anxiety in primary care. Closing the gap between knowledge and practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Drug treatment of depression in the 1990s. An overview of achievements and future possibilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Prospects for improved antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

The treatment of depressive states with G 22355 (imipramine hydrochloride).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Plant-derived anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Inhibition of monoamine oxidase by hypericin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Peroxides as Constituents of Plants, Part 19: A C50-Hydroperoxide fromHypericum perforatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

Researching alternative medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900299-9

10.1016/S0024-3205(98)00299-9

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference